It looks like you are using an outdated browser which may lead to usability issues.
We highly encourage you adopt a modern browser before proceeding.
Click here
Head & Neck Cancer Alliance
A Phase III Xevinapant and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRay Vision™)